Sec filings asrt

Author: hsus

August undefined, 2024

Web11 May 2024 · Assertio Therapeutics, Inc (ASRT) SEC Filing 10-Q Quarterly report for the period ending Tuesday, March 31, 2024. Home. SEC Filings. Assertio Therapeutics, Inc … Web17 Mar 2024 · State Street Corp increased its holdings in shares of Assertio by 6.9% during the 3rd quarter. State Street Corp now owns 142,064 shares of the company's stock …

Assertio Therapeutics, Inc (ASRT) SEC Filing 10-Q Quarterly report …

WebView the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations. Get daily stock ideas from top-performing Wall Street analysts. Web13 Mar 2024 · 0001808665 2024-03-10 2024-03-10 iso4217:USD xbrli:shares iso4217:USD corneal lens rgp

Assertio Holdings, Inc. (ASRT) Stock Price Today, Quote & News

Web15 Dec 2024 · ASRT Assertio Holdings Inc Current Report Filing (8-k) 0001808665 false 0001808665 2024-12-14 2024-12-14 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANG... Web9 May 2024 · Assertio Therapeutics, Inc (ASRT) SEC Filing 10-Q Quarterly report for the period ending Sunday, March 31, 2024. Home. SEC Filings. Assertio Therapeutics, Inc … Web14 Apr 2024 · Assertio Holdings, Inc. (NASDAQ:ASRT) announced its earnings results on Wednesday, March, 8th. The company reported $1.34 earnings per share for the quarter, … corneal melt eyewiki

ASRT Fair Value Price Assertio Holdings - marketchameleon.com

Assertio Holdings, Inc. Common Stock (ASRT) SEC …

WebExplore Assertio Holdings (ASRT) seasonal trends in implied volatility, historical volatility, and option volume. Compare average values for each day of the year, dating back to 2014. WebASRT: Lowering target price to $5.00 ASSERTIO THERAPEUTICS INC has an Investment Rating of HOLD; a target price of $5.00; an Industry Subrating of High; a Management … corneal laceration icd 9WebInstitutional Ownership and Shareholders. Assertio Holdings Inc (US:ASRT) has 120 institutional owners and shareholders that have filed 13D/G or 13F forms with the … fangraphs andy pages

"WebAssertio Holdings, Inc. (ASRT) NasdaqCM - NasdaqCM Real Time Price. Currency in USD. Follow. 2W 10W 9M. 6.11 -0.10 (-1.61%) At close: 04:00PM EST. 6.15 +0.04 (+0.65%) After … " - Sec filings asrt

Sec filings asrt

Web8 Mar 2024 · SEC gov • March 08, 2024. ASRT : 10-K Annual report pursuant to Section 13 and 15(d) Symbol. ASRT. ... Related Filings from ASRT. ARS Annual report to security … Web2 days ago · The high end of $26.5 billion for 2024 points to a 1.8% decline from last year (Table 1) and is currently below analyst expectations by $220 million. Excluding Veklury, $24.5 billion represents a ...

Did you know?

Web6 Apr 2024 · ASRT Earnings Date and Information Assertio last announced its earnings results on March 8th, 2024. The reported $1.34 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.23 by $1.11. The company earned $50.35 million during the quarter, compared to analyst estimates of $49.57 million. Web13 Apr 2024 · A high-level overview of Assertio Holdings, Inc. (ASRT) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

WebAs I've stated in my ASRT DD & shown in their SEC filings regarding the merger, once the merger is completed, which happened yesterday, Zyla shareholders will be receiving their alloted shares of ASRT, which is 2.5 shares per each Zyla they were previously holding. Once that is complete, the stock will be back up. Web11 Mar 2024 · Assertio Therapeutics, Inc (ASRT) SEC Filing 10-K Annual report for the fiscal year ending Monday, December 31, 2024

WebAssertio Holdings Inc. SEC filings breakout by MarketWatch. View the ASRT U.S. Securities and Exchange Commission reporting information. Skip to main contentMain Menu Home Latest News... WebSEC Filings for Assertio Therapeutics Inc (ASRT) including Annual 10-K and Quarterly 10-Q Reports. Your browser of choice has not been tested for use with Barchart.com. If you …

Web24 Mar 2024 · Assertio Holdings, Inc. (FormPRE 14A) - Assertio Holdings (NASDAQ:ASRT) - Benzinga TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE …

WebASRT / Assertio Holdings Inc - SEC Filings, Annual Report, Proxy Statement EXTENDED CIK 1808665 Overview Owners Insiders Short Interest Options Filings Financials Dividends … corneal lens implant treatmentWebFind the latest SEC Filings data for Assertio Holdings, Inc. Common Stock (ASRT) at Nasdaq.com. fangraphs andrew heaneyWeb9 rows · 7 Feb 2024 · Find the latest SEC Filings data for Assertio Holdings, Inc. Common Stock (ASRT) at ... corneal light reflex testsWebSEC Filings are formal documents required by the government that describe the financial health and operating activities for any company that has publicly traded stock. The … fangraphs and baseball reference warWeb10 Mar 2024 · The following information was filed by Assertio Therapeutics, Inc (ASRT) on Monday, March 9, 2024 as an 8K 2.02 statement, which is an earnings press release … corneal myersWeb9 Aug 2024 · Ticker: ASRT CIK: 1005201 Form Type: 8-K Corporate News Accession Number: 0001104659-19-045097 Submitted to the SEC: Fri Aug 09 2024 4:01:32 PM EST … fangraphs andrew vaughnWebASRTMENU ASRTMENU CLOSE STOCK INFO Summary Chart Dividends Price Action Historical Data Insider Trades FUNDAMENTALS Summary Peer Comps Fair Value Payback Period Income Statement Cash Flow Statement Balance Sheet EARNINGS Interactive Charts Release Dates Implied Moves And IV Crush Earnings Moves Option Strategies EPS … corneal macrophages